**Core Concept**
Follicular carcinoma of the thyroid is a type of cancer that originates from the follicular cells of the thyroid gland. The development of follicular carcinoma is closely linked to genetic mutations that disrupt the normal functioning of thyroid cells.

**Why the Correct Answer is Right**
The correct answer is related to the RAS gene, which plays a crucial role in cell signaling and proliferation. Mutations in the RAS gene are common in follicular thyroid cancer and lead to the activation of downstream signaling pathways, promoting cell growth and tumor formation. Specifically, the RAS gene mutation leads to the substitution of glutamic acid for valine at position 599 (V599E), which is a hallmark of follicular thyroid cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** BRAF V600E mutation is more commonly associated with papillary thyroid cancer, not follicular carcinoma.
**Option B:** RET/PTC rearrangement is a characteristic genetic alteration in papillary thyroid cancer, not follicular carcinoma.
**Option C:** PAX8/PPARγ rearrangement is not typically associated with follicular thyroid cancer.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that RAS mutations in thyroid cancer are often not detectable by routine genetic testing, but can be identified by more sensitive techniques such as next-generation sequencing.

**Correct Answer:** C.